We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Servier to Purchase Agios Pharmaceuticals’ Oncology Business for Up to $2 Billion
Servier to Purchase Agios Pharmaceuticals’ Oncology Business for Up to $2 Billion
French drugmaker Servier is expanding its reach into cancer drugs by acquiring Agios Pharmaceutical’s oncology business in a deal valued at up to $2 billion.